Newsroom
Sorted by: Latest
-
HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- 04-August-2026 Issue: Mitsubishi HC Capital UK Plc Series 852 XS2809655967 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 08-May-2026 Date To: 10-August-2026 Record Date: 07-August-2026 Value Date: 10-August-2026 Benchmark Rate: 3.62637% Margin: 1% Total Rate: 4.62637% Floor: 0% Number of Days: 94 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount Due: USD 241,...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 03.08.2026 IPXE.IM IE00BFD26097 50,002.00 EUR 1,235,339.04 24.706 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 03.08.2026 NQCYBREN IE00BF16M727 27,069,725.00 USD 1,573,846,682.66 58.140 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 03.08.2026 FDNU IE00BG0SSC32 1,150,002.00 USD 44,899,216.19 39.043 ...
-
HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- 03-August-2026 Issue: Bank of Montréal Series 302 XS2552384930 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 11-May-2026 Date To: 10-August-2026 Record Date: 07-August-2026 Value Date: 10-August-2026 Benchmark Rate: 3.62659% Margin: 1.2% Total Rate: 4.82659% Number of Days: 91 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount Due: USD 610,027.35 Interest Per...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 03.08.2026 CPQ IE00BFD2H405 6,400,002.00 USD 397,875,483.10 62.168 ...
-
HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- 03-August-2026 Issue: Mitsubishi HC Capital UK Plc Series 953 XS3176435785 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 11-May-2026 Date To: 10-August-2026 Record Date: 07-August-2026 Value Date: 10-August-2026 Benchmark Rate: 3.62482% Margin: 0.45% Total Rate: 4.07482% Floor: 0% Number of Days: 91 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount Due: USD 3...
-
Riassunto: LabPMM® lancia il servizio di valutazione globale MRD KMT2A a sostegno dello sviluppo dell'inibitore della menina e della cura della leucemia acuta
SAN DIEGO--(BUSINESS WIRE)--LabPMM®, una filiale di Invivoscribe®, ha annunciato oggi la disponibilità a livello globale del suo nuovo servizio di valutazione della malattia residua misurabile (MRD) KMT2A. Il servizio di PCR digitale ad alta sensibilità è a disposizione di operatori sanitari, ricercatori clinici e partner biofarmaceutici attraverso la rete globale di laboratori di LabPMM; negli Stati Uniti sono disponibili test accreditati CAP/CLIA. Il servizio risponde alla crescente esigenza...
-
LabPMM® lance un service mondial de dépistage de la maladie résiduelle mesurable (MRM) KMT2A pour soutenir le développement d’inhibiteurs de la ménine et la prise en charge de la leucémie aiguë
SAN DIEGO--(BUSINESS WIRE)--LabPMM®, filiale d’Invivoscribe®, a annoncé aujourd’hui la mise à disposition mondiale de son nouveau service de dépistage de la maladie résiduelle mesurable (MRM) KMT2A. Ce service de PCR numérique hautement sensible est accessible aux professionnels de santé, aux chercheurs cliniques et aux partenaires biopharmaceutiques via le réseau mondial de laboratoires de LabPMM, les tests étant accrédités CAP/CLIA aux États-Unis. Ce service répond à un besoin croissant de su...
-
VivaMed BioPharma Announces Formation of Board of Directors
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--VivaMed BioPharma today announced the formation of its Board of Directors, bringing together leaders in healthcare delivery, pharmaceutical research and manufacturing, public-company leadership, and corporate governance to guide the company’s next phase of growth.The Board will provide strategic oversight as VivaMed advances its mission to transform healthcare through innovative solutions that improve patient outcomes and expand access to high-quality care. It...